More From Our Sponsor:
Avita Care Solutions

SPONSORED CONTENT

While health leaders have touted the “whole health” approach of integrated healthcare for decades as a way to provide patients with better, more cost-effective care, the COVID-19 pandemic significantly accelerated the adoption and implementation of this model by prompting rapid expansions in telehealth and highlighting the importance of cross-functional collaboration of medical specialties.

In a changing 340B environment, why should covered entities leverage this model to secure their missions and better serve their communities? Dr. Jennifer Peña, medical director at Q Care Plus (an Avita Care Solutions company) and a former White House physician, explains below and includes actionable tips for entities at all stages of adopting integrated care.

To make sure we’re all on the same page in terms of definition, how would you describe an integrated healthcare model as it applies to covered

SPONSORED CONTENT

For over 35 years, Avita Care Solutions’ Chief Medical Officer, Dr. Christopher Hall, has devoted his career to democratizing and scaling compassionate and competent care initiatives to underserved communities—the very patients the 340B program was designed to help. In the following interview, he offers a provider’s point of view on why the drug discount program is essential to even the health equity playing field and on how clinicians play a fundamental role in securing its sustainable future.

Question: How long have you been serving marginalized patients with the help of safety net funding from the 340B drug discount program?

Dr. Hall: I’ve been working with clinical programs associated with the 340B program for just shy of 20 years. My very first interaction with 340B was as the medical co-director of a large HIV clinic in Oakland, California, which was associated with a disproportionate share hospital (DSH) and received Ryan White Care

SPONSORED CONTENT

Saving people’s lives.
Eliminating the stigma surrounding a host of physical and mental health conditions.
Advocating for the health equity of underserved populations.
Executing targeted marketing campaigns.

One of these initiatives indeed feels less service-oriented than the others. But once you kick all its associated buzzwords to the curb, marketing is crucial to a covered entity’s ability to fulfill its vision.

Whether it’s because they’re too busy fighting fires, feel like they don’t have the financial resources, or believe they lack the expertise to get the word out about their services successfully, covered entities often shy away from strategic marketing plans. Unfortunately, doing so can keep them from attracting and retaining patients and, as a result, threaten the sustainability of their missions.

Read on as Avita Care Solution’s Chief Marketing Officer Liz Eckert and Chief Advocacy Officer Glen Pietrandoni explain why covered entities must thoughtfully promote themselves to patients in an

SPONSORED CONTENT

It’s that time again: The 340B Coalition Winter Conference, known as the can’t-miss gathering of covered entities, health care providers, pharmacy and pharmacy service providers, drug manufacturers, government agencies, and other organizations dedicated to driving health equity for underserved populations via the 340B drug discount program, is just around the corner.

Over the course of three days, the event draws thousands of industry insiders, features a full program of educational, networking, and demo sessions, and showcases approximately 70 exhibitors. But with so much on the agenda—during a critical year for insights and collaboration into the changing 340B world—how can attendees get the most bang for their collective bucks?

Find out below as Avita Care Solutions leaders (and veteran 340B Coalition Conference-goers) Michael Yount and Lee Horner weigh in with tips on using the event to find thought leaders and make lasting partnerships. And don’t